Go to the list of all blogs
Jonathan Merton's Avatar
published in Blogs
Sep 08, 2023

Diabetes Stocks $NURO, $DRIO, $ORGS, and $DMAC Soar with +11.13% Weekly Gain

Tickers in the group - $NURO$DRIO$ORGS$DMAC

The Diabetes sector has been making headlines recently with a remarkable surge in performance, recording an impressive +11.13% increase over the past week. This surge has sparked considerable interest among investors and analysts alike. In this article, we'll delve into the details of this theme, focusing on the four key tickers that have been at the forefront of this trend: NURO, DRIO, ORGS, and DMAC.

Positive Outlook with Strong Volume Indicator Support

One of the key indicators of the positive outlook for these stocks is the Volume Indicator. This indicator suggests that the market sentiment towards these companies is favorable. Additionally, Tickeron, a notable source for market predictions, is also optimistic about this group, projecting a potential further increase of over 4.00% within the next month with a likelihood of 44%. These optimistic forecasts have captured the attention of investors looking for growth opportunities in the market.

RSI Indicator Confirms the Bullish Sentiment

The Relative Strength Index (RSI) is a widely followed technical indicator used to identify overbought or oversold conditions in a stock. In the case of these diabetes-related stocks, the RSI indicator has been sending positive signals. Notably, four stocks in this group have confirmed their positive outlook based on the RSI indicator, with an average probability of success standing at an impressive 89%. This further bolsters the case for a bullish trend in this sector.

Market Cap Variation

The market capitalization of the companies within the diabetes theme varies significantly. On average, these companies have a market capitalization of approximately $60.1 million. Among the four tickers in focus, DMAC holds the highest valuation, commanding a market capitalization of $126.4 million. On the other end of the spectrum, PHASQ is the lowest valued company in this group, with a market capitalization of only $15,000. This wide range of market caps within the theme highlights the diversity of investment opportunities available in the diabetes sector.

Price Performance and Notable News

The price performance of these diabetes-related stocks has been noteworthy. On a weekly basis, the average price growth across all stocks in this theme was an impressive 11.13%, demonstrating strong short-term potential. However, it's important to note that the average monthly and quarterly price growth figures were -11.91% and -6.37%, respectively. ORGS stands out as the top performer in terms of weekly price growth, surging by an impressive 21.59%. Conversely, DRIO experienced a minor dip of -0.63% during the same period.

Volume Fluctuations

Analyzing volume fluctuations provides insight into investor interest and activity in these stocks. On a weekly basis, the average volume growth across all stocks in the diabetes theme was -26.47%, indicating some short-term volatility in trading volumes. Monthly and quarterly volume growth figures showed a similar trend, with averages of -19.93% and -64.01%, respectively. Notably, there were specific instances of significant volume increases, such as DarioHealth (DRIO) experiencing record-breaking daily growth of 239% of the 65-Day Volume Moving Average on 8/16/23.

Key Ticker Analysis

Let's take a closer look at three of the key tickers within this theme:

  1. NURO: The RSI indicator for NURO moved out of oversold territory on August 28, 2023, signaling a potential shift from a downward trend to an upward one. The odds of a move higher are estimated at 88%. Despite recent challenges, NURO is showing signs of a recovery, with a positive uptrend in the week of 08/29/23 - 09/06/23.

  2. DRIO: DRIO's RSI Oscillator left oversold territory on August 22, 2023, indicating a possible shift towards an upward trend. The odds of a move higher stand at an impressive 90%. While DRIO has faced a recent downtrend, the week of 08/29/23 - 09/06/23 showed signs of a modest uptrend.

  3. ORGS: ORGS' RSI Oscillator moved out of oversold territory on September 01, 2023, suggesting a shift towards an upward trend. The odds of a move higher are estimated at 84%. This stock experienced a significant uptrend during the week of 08/29/23 - 09/06/23, with a noteworthy 30% increase.

In summary, the diabetes sector has recently witnessed a surge in performance, with positive indicators like the Volume Indicator and RSI suggesting a bullish outlook. Investors should closely monitor these stocks, particularly NURO, DRIO, and ORGS, as they exhibit strong potential for future growth. However, it's essential to consider the inherent volatility in this sector and conduct thorough research before making investment decisions.

Related Ticker: NURO, DRIO, ORGS, DMAC

Momentum Indicator for NURO turns negative, indicating new downward trend

NURO saw its Momentum Indicator move below the 0 level on September 15, 2023. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned negative. In of the 91 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NURO turned negative on September 19, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NURO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NURO entered a downward trend on September 01, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for NURO's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NURO advanced for three days, in of 216 cases, the price rose further within the following month. The odds of a continued upward trend are .

NURO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.273) is normal, around the industry mean (24.997). P/E Ratio (0.000) is within average values for comparable stocks, (80.562). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.291). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.714) is also within normal values, averaging (62.158).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NURO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NURO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.43B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -6%. AVGR experienced the highest price growth at 198%, while HSCS experienced the biggest fall at -54%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 31%. For the same stocks of the Industry, the average monthly volume growth was 6% and the average quarterly volume growth was 104%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 58
SMR Rating: 83
Profit Risk Rating: 87
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of medical devices used for treatment of the neurological complications of diabetes

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
4B Gill Street
Phone
+1 781 890-9989
Employees
27
Web
https://www.neurometrix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UVSP17.160.10
+0.59%
Univest Financial Corp
EGO10.050.05
+0.50%
Eldorado Gold Corp
MDV14.48-0.03
-0.17%
Modiv Industrial
PXMD0.30N/A
-0.36%
PaxMedica
EME215.01-1.44
-0.67%
EMCOR Group

NURO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NURO has been loosely correlated with AVNS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NURO jumps, then AVNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NURO
1D Price
Change %
NURO100%
+6.54%
AVNS - NURO
38%
Loosely correlated
-0.78%
LIVN - NURO
29%
Poorly correlated
-0.35%
OFIX - NURO
29%
Poorly correlated
-1.16%
TMDX - NURO
27%
Poorly correlated
-1.81%
EXAS - NURO
25%
Poorly correlated
-3.54%
More
Artificial intelligence (AI) technology is developing rapidly.Data mining can deliver raw numbers, but it does not necessarily provide actionable insights. Structure is necessary to taking abstract information and extracting commonalities, like averages, ratios, and percentages.
You have enough faith in that stock, based on research, that the return will equal or exceed the investment.  Do unto others.The principles outlined here will ensure that happens.  Principle #1: Diversification Investors can’t be one-dimensional when constructing a portfolio.
Some of the world’s biggest financial institutions have devoted multi-million dollar budgets to developing algorithms that can find patterns in the market, identify trends, and perform automated trading designed to take advantage of even the smallest price movements. The AI revolution is so big that as it stands today, the world’s five biggest hedge funds all use systems-based approaches to trade financial markets.Indeed, quantitative trading hedge funds now manage $918 billion (according to HFR), which amounts to 30% of the $3 trillion hedge fund industry – a percentage continues to grow with each year that passes.
Where smaller, more volatile companies can placate shareholders with higher returns, larger companies often use dividend payouts to entice new investors and hold their existing ones. These low-risk options may not work for every investment approach, but dividend-producing stocks can offer great benefits under the right circumstances – especially for portfolios built for the long-term.Beyond the ability to rely on these semi-regular payouts as an income stream – a strategy favored by retirees – dividends are an excellent vehicle for compounding earnings through reinvestment.
Artificial intelligence (AI) and fintech have an inherent compatibility that has become clearer as each sector has matured, with recent growth and successes on their own accord bringing new ideas about how they can work together.AI can analyze information at far greater quantities (and far more quickly) than any human, making it a natural fit to help fintech firms streamline and automate processes that benefit customers and businesses alike. Fintech has brought a revolution of convenience to the finance world.
You’ve set up your bitcoin wallet and have acquired some bitcoins, and now you’re ready to use them – what’s next?But be VERY careful to double- or triple-check that the address is correct – crypto transactions are irreversible, and a typo almost certainly means permanently losing the bitcoins you were trying to send. One way to avoid potential slip-ups is to scan a QR code (when available) for the destination address.
Mainstream acceptance has come in fits and starts, with regulatory approval proving hard to come by for a variety of reasons – not least of which the ever-present risk of theft via hacking or other means, which pose an especially large obstacle to attracting investment from mainstream institutions. Because crypto holdings are only accessible via a specific private key, they are susceptible to loss – literally, if the key is written on a piece of paper or a physical hard drive, methods of offline ‘cold storage’ – or through hacks if held in an online wallet.Reuters reports that over $800 million in crypto assets were stolen in the first half of 2018, creating justifiable concern for both owners and mainstream financial institutions alike. Some type of insurance coverage would potentially mitigate the risks inherent to owning crypto assets – if insurers are willing to play ball.
Don't fall prey to common financial traps that can derail your financial planning efforts. In this article, we highlight four traps to keep in mind, including the importance of refinancing rather than consolidating student loans and credit card debt, prioritizing debt repayment over investments, limiting news consumption, and understanding the true costs of buying a home. Learn how AI tools from Tickeron can help investors make informed decisions and achieve their investment objectives.
Paper wallets are extremely useful tools – beyond being one of the most popular and secure cold storage methods, they make it simple to transfer coins between owners.You can access the funds on your paper wallet by “sweeping” (or importing) them to either a live wallet (like Trezor or Exodus) or an exchange service (like Coinbase). Most services allow you to import them directly from your wallet’s private key, but there are two key exceptions.
Get ready to revolutionize your investment strategy! Discover 3 cutting-edge ways to get fresh and innovative investment ideas, and say goodbye to relying on unreliable sources like CNBC. From utilizing advanced AI tools to sharing your portfolio with trusted friends, these methods are sure to boost your investment game. So, what are you waiting for? Read on to find out how you can start generating new ideas today!
You’re a trader, not an investor. It’s important that you understand the difference before choosing an actual trading style. Traders perform their magic over shorter periods of time, sometimes within minutes or hours. Investors are more passive. They purchase equities and hold them for months or years, relying on a long-term return. Traders evaluate buys and sells based on technical analysis...
Looking to invest your money in the stock market? While leaving your money there for a few years can yield a ten percent return, real traders know that actively trading and using derivatives is the way to make a significant profit while minimizing risk. Derivatives are contracts between two parties that are based on the price of a financial asset, such as a stock or bond. The value of the...
Zoom (ZOM), the video conferencing giant, registered a three-day uptrend of +1.84%. Our proprietary AI trading bot identified an intraday gain of 6.75%, attributing it to robust market sentiment and promising growth indicators. This uptrend signals a potentially strong position for investors and stakeholders. A deeper analysis could provide crucial insights into the future performance of ZOM. Stay updated for further analytics and forecast from our AI tools.
The Swing Trader: Volatility Balanced Strategy (TA) AI trading robot has emerged as a remarkable performer. Operating within our robot factory, this trading algorithm has recently demonstrated its prowess by generating a notable gain of 3.74% while trading ZIM (ZIM Integrated Shipping Services Ltd) over the previous week. This article aims to delve into the technical analysis surrounding ZIM's recent performance and the potential for an impending price rebound.
AI trading robot, the Swing trader: Volatility Balanced Strategy (TA), has stood out as a performer in our robot factory. In the previous week, it achieved an impressive 3.78% gain while trading AFRM (Affirm Holdings Inc.), a notable stock in the market. In this article, we will delve into the technical analysis of AFRM's recent movements and explore the implications of its earnings results.
Among them, the Swing Trader: Volatility Balanced Strategy (TA) stands out as a top-performing AI trading robot. In the previous week, this robot demonstrated its prowess by generating an impressive 3.60% gain while trading NET (stock ticker symbol) – a remarkable achievement. This article delves into the reasons behind the success of Swing Trader, focusing on the positive Moving Average Convergence Divergence (MACD) indicator and the recent earning results of NET.
The Swing Trader: Volatility Balanced Strategy (TA), has caught our attention for its impressive performance. Last week, it generated a remarkable gain of 3.56% while trading RIOT, a prominent stock. In this article, we will delve into the analysis of RIOT's recent bearish trend and examine the company's earnings results, which exceeded expectations.
The Swing Trader: Volatility Balanced Strategy (TA) AI trading robot has emerged as a top performer in our robot factory, demonstrating exceptional performance and generating significant gains. In the previous week, this intelligent trading bot achieved a remarkable 3.56% gain while trading WKHS (Workhorse Group Inc.) - an achievement worth noting. Coupled with positive market indicators, WKHS presents an intriguing opportunity for potential future growth.
AI trading robot, known as "Swing trader: Volatility Balanced Strategy (TA)," has caught the attention of traders and investors alike. In the previous week, this AI robot, developed in our esteemed robot factory, demonstrated impressive performance by generating a gain of 3.51% while trading DKNG. This article will delve into the recent trading activity, the significance of the stock's upward trend, and analyze the latest earnings results of DKNG.
One such tool that has garnered attention is the AI trading robot known as Swing trader: Volatility Balanced Strategy (TA). This robot, developed in our esteemed factory, recently demonstrated its prowess by generating a notable 3.02% gain while trading CHPT (ChargePoint Holdings) over the previous week. While CHPT experienced a downward trend, the robot's performance and insightful analysis provide valuable insights for traders and investors alike.